Poxel Announces Detailed Imeglimin Phase 3 TIMES 1 Results Presented at 55th Annual Meeting of the European Association for the Study of Diabetes

Press/Media: Press / Media

PeriodSep 17 2019 → Sep 18 2019

Media coverage

14

Media coverage

  • TitlePoxel Announces Detailed Imeglimin Phase 3 TIMES 1 Results Presented at 55th Annual Meeting of the European Association for the Study of Diabetes
    Media name/outletMorningstar.com
    CountryUnited States
    Date9/18/19
    PersonsRalph A Defronzo
  • TitlePoxel Announces Detailed Imeglimin Phase 3 TIMES 1 Results Presented at 55th Annual Meeting of the European Association for the Study of Diabetes
    Media name/outletFinanzen.net
    CountryGermany
    Date9/18/19
    PersonsRalph A Defronzo
  • TitlePoxel Announces Detailed Imeglimin Phase 3 TIMES 1 Results Presented at 55th Annual Meeting of the European Association for the Study of Diabetes
    Media name/outletFinanzen.ch
    CountrySwitzerland
    Date9/18/19
    PersonsRalph A Defronzo
  • TitlePoxel Announces Detailed Imeglimin Phase 3 TIMES 1 Results Presented at 55th Annual Meeting of the European Association for the Study of Diabetes
    Media name/outletMarketScreener.com
    CountryUnited States
    Date9/18/19
    PersonsRalph A Defronzo
  • TitlePoxel Announces Detailed Imeglimin Phase 3 TIMES 1 Results Presented at 55th Annual Meeting of the European Association for the Study of Diabetes
    Media name/outletBoerse.de
    CountryGermany
    Date9/18/19
    PersonsRalph A Defronzo
  • TitlePoxel Announces Detailed Imeglimin Phase 3 TIMES 1 Results Presented at 55th Annual Meeting of the European Association for the Study of Diabetes
    Media name/outletIndia Pharma News
    CountryIndia
    Date9/18/19
    PersonsRalph A Defronzo
  • TitlePoxel Announces Detailed Imeglimin Phase 3 TIMES 1 Results Presented at 55th Annual Meeting of the European Association for the Study of Diabetes
    Media name/outletBioSpace
    CountryUnited States
    Date9/18/19
    PersonsRalph A Defronzo
  • TitlePoxel Announces Detailed Imeglimin Phase 3 TIMES 1 Results Presented at 55th Annual Meeting of the European Association for the Study of Diabetes
    Media name/outletJotup
    CountryUnited States
    Date9/18/19
    PersonsRalph A Defronzo
  • TitlePoxel Announces Detailed Imeglimin Phase 3 TIMES 1 Results Presented at 55th Annual Meeting of the European Association for the Study of Diabetes
    Media name/outletFinanzNachrichten.de
    CountryGermany
    Date9/18/19
    PersonsRalph A Defronzo
  • TitlePoxel Announces Detailed Imeglimin Phase 3 TIMES 1 Results Presented at 55th Annual Meeting of the European Association for the Study of Diabetes
    Media name/outletErie News Now
    CountryUnited States
    Date9/18/19
    PersonsRalph A Defronzo
  • TitlePoxel Announces Detailed Imeglimin Phase 3 TIMES 1 Results Presented at 55th Annual Meeting of the European Association for the Study of Diabetes
    Media name/outletCW WBCB
    CountryUnited States
    Date9/18/19
    PersonsRalph A Defronzo
  • TitlePoxel Announces Detailed Imeglimin Phase 3 TIMES 1 Results Presented at 55th Annual Meeting of the European Association for the Study of Diabetes
    Media name/outletBusiness Wire
    CountryUnited States
    Date9/18/19
    PersonsRalph A Defronzo
  • TitlePoxel Announces Detailed Imeglimin Phase 3 TIMES 1 Results Presented at 55th Annual Meeting of the European Association for the Study of Diabetes
    Media name/outletBusiness Wire
    CountryUnited States
    Date9/18/19
    PersonsRalph A Defronzo
  • TitlePoxel Announces Detailed Imeglimin Phase 3 TIMES 1 Results Presented at 55th Annual Meeting of the European Association for the Study of Diabetes
    Media name/outletAcrofan
    Date9/17/19
    PersonsRalph A Defronzo